Description
Mirabegron is selective beta 3-adrenoceptor agonist available as a 25 mg and 50 mg extended-release (ER) tablet. It is approved for the treatment of OAB with symptoms of urgency, urgency incontinence, and urinary frequency.
| Strength | 25mg |
| Pack Size | Not specified |
| Brand | Mbgron |
| Packaging Type | Box |
| Composition | Mirabegron 25mg |
| Form | Not specified |
| Shelf Life | 36 Months |
| Usages | Overactive Bladder Treatment |
| Country of Origin | Not specified |
